Results 171 to 180 of about 9,143 (202)
Activation of RBM5 by HPV16 E7.
E7 molecular functions, binding partners and network interactants remain incompletely defined. We studied E7 molecular function through measurement of total transcription by RNA-sequencing in HPV- C33A cells following ectopic expression of HPV16 E7. We demonstrate here activation of Rbm5 by HPV16 HPV E7.
openaire +1 more source
Activation of PROCA by HPV16 E7.
E7 molecular functions, binding partners and network interactants remain incompletely defined. We studied E7 molecular function through measurement of total transcription by RNA-sequencing in HPV- C33A cells following ectopic expression of HPV16 E7. We demonstrate here activation of the protein interacting with cyclin A1 encoded by Proca by HPV16 HPV ...
openaire +1 more source
Activation of POLL by HPV16 E7.
E7 molecular functions, binding partners and network interactants remain incompletely defined. We studied E7 molecular function through measurement of total transcription by RNA-sequencing in HPV- C33A cells following ectopic expression of HPV16 E7. We demonstrate here activation of Poll by HPV16 HPV E7.
openaire +1 more source
E7 molecular functions, binding partners and network interactants remain incompletely defined. We studied E7 molecular function through measurement of total transcription by RNA-sequencing in HPV- C33A cells following ectopic expression of HPV16 E7. We demonstrate here activation of Phf1 and Phf7 by HPV16 HPV E7.
openaire +1 more source
Activation of Slc49a3 by HPV16 E7.
E7 molecular functions, binding partners and network interactants remain incompletely defined. We studied E7 molecular function through measurement of total transcription by RNA-sequencing in HPV- C33A cells following ectopic expression of HPV16 E7. We demonstrate here activation of Slc49a3 by HPV16 HPV E7.
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biotechnology and Applied Biochemistry, 2022
AbstractQuality control is very important during the development of 3‐valent (16/18/58), 9‐valent (6/11/16/18/31/33/45/52/58), and 15‐valent human papillomavirus (HPV) vaccines (6/11/16/18/31/33/35/39/45/52/56/58/59/68). All 3‐valent, 9‐valent, and 15‐valent HPV vaccines contain the HPV16 antigen; therefore, a detection method that can specifically ...
Yuying Liu +8 more
openaire +2 more sources
AbstractQuality control is very important during the development of 3‐valent (16/18/58), 9‐valent (6/11/16/18/31/33/45/52/58), and 15‐valent human papillomavirus (HPV) vaccines (6/11/16/18/31/33/35/39/45/52/56/58/59/68). All 3‐valent, 9‐valent, and 15‐valent HPV vaccines contain the HPV16 antigen; therefore, a detection method that can specifically ...
Yuying Liu +8 more
openaire +2 more sources
Combo Approaches for HPV16+ Cancers
Cancer Discovery, 2021Abstract Beyond anti–PD-1 therapy as a mainstay, additional strategies are being developed for HPV-associated cancers. Emerging data from two ongoing trials have shown some early efficacy with vaccines directed at HPV16-specific E6 and E7 viral oncoproteins, as well as with other therapies targeting different facets of antitumor immunity.
openaire +2 more sources
Ii-Key/HPV16 E7 hybrid peptide immunotherapy for HPV16+ cancers
Vaccine, 2009Activation of antigen-specific CD4+ T cells is critical for vaccine design. We have advanced a novel technology for enhancing activation of antigen-specific CD4+ T helper cells whereby a fragment of the MHC class II-associated invariant chain (Ii-Key) is linked to an MHC class II epitope. An HLA-DR4-restricted HPV16 E7 epitope, HPV16 E7(8-22), was used
Minzhen, Xu +5 more
openaire +2 more sources
Acta Cytologica, 2009
To determine whether the absence ofHPV1i6 LI capsid protein is a prognostic parameter for the histologic outcome of cervical intraepithelial neoplasia (CIN) 2+ in cytologically diagnosed cervical dysplasia.Papanicolaou-stained microscopic slides of 95 HPV16-positive cervical samples that had a cytologic diagnosis of cervical dysplasia or borderline ...
Siegfried, Kösel +3 more
openaire +2 more sources
To determine whether the absence ofHPV1i6 LI capsid protein is a prognostic parameter for the histologic outcome of cervical intraepithelial neoplasia (CIN) 2+ in cytologically diagnosed cervical dysplasia.Papanicolaou-stained microscopic slides of 95 HPV16-positive cervical samples that had a cytologic diagnosis of cervical dysplasia or borderline ...
Siegfried, Kösel +3 more
openaire +2 more sources

